Please login to the form below

Not currently logged in
Email:
Password:

Kathryn Gallant leaves Hall & Partners to join Insight Health US

Appointed joint CEO alongside Jessica Cunningham

Kathryn Gallan, Insight Health USConsultancy firm Insight Health US has appointed former managing partner at Hall & Partners Kathryn Gallant as joint CEO.

Gallant joins fellow CEO Jessica Cunningham at the New York-based firm, where she replaces Avanti Ananthram who is due to move to the UK to become head of international development at parent company Insight Research Group.

Gallant's duties will include driving the growth of Insight Health US.

In total, Gallant has 14 years' experience in market research spanning both global and US domestic healthcare research, eight of which have been at Hall & Partners.

Prior to this, she was a director at Strategic Marketing Corporation.

Jane Shirley, CEO of Insight Research Group, said: “We are delighted that Kathryn will be joining us to help drive the next stage of Insight's growth in the US. Kathryn has a great reputation within the industry that fits perfectly with Insight's focus on delivering top quality, truly insightful research.”

15th January 2013

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics